[go: up one dir, main page]

AU6268199A - Live virus vaccines to protect primates from hiv-1 infection and disease - Google Patents

Live virus vaccines to protect primates from hiv-1 infection and disease

Info

Publication number
AU6268199A
AU6268199A AU62681/99A AU6268199A AU6268199A AU 6268199 A AU6268199 A AU 6268199A AU 62681/99 A AU62681/99 A AU 62681/99A AU 6268199 A AU6268199 A AU 6268199A AU 6268199 A AU6268199 A AU 6268199A
Authority
AU
Australia
Prior art keywords
hiv
infection
disease
live virus
virus vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62681/99A
Inventor
Opendra Narayan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas Medical Center
Original Assignee
University of Kansas Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas Medical Center filed Critical University of Kansas Medical Center
Publication of AU6268199A publication Critical patent/AU6268199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62681/99A 1998-09-29 1999-09-28 Live virus vaccines to protect primates from hiv-1 infection and disease Abandoned AU6268199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10214398P 1998-09-29 1998-09-29
US60102143 1998-09-29
PCT/US1999/022349 WO2000018430A2 (en) 1998-09-29 1999-09-28 Live virus vaccines to protect primates from hiv-1 infection and disease

Publications (1)

Publication Number Publication Date
AU6268199A true AU6268199A (en) 2000-04-17

Family

ID=22288338

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62681/99A Abandoned AU6268199A (en) 1998-09-29 1999-09-28 Live virus vaccines to protect primates from hiv-1 infection and disease

Country Status (4)

Country Link
EP (1) EP1109575A2 (en)
AU (1) AU6268199A (en)
CA (1) CA2345959A1 (en)
WO (1) WO2000018430A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015DN03026A (en) * 2012-09-11 2015-10-02 Univ California

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050070A1 (en) * 1997-05-02 1998-11-12 University Of Kansas Medical Center Live virus vaccines to protect primates from hiv-1 infection and disease

Also Published As

Publication number Publication date
EP1109575A2 (en) 2001-06-27
WO2000018430A3 (en) 2000-07-06
CA2345959A1 (en) 2000-04-06
WO2000018430A2 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
PT1150712E (en) Human papilloma virus vaccine formulations
GB2337755B (en) Virus vaccine
SI0831921T1 (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
HUP0103908A3 (en) Novel infulenza virus vaccine composition
IS5191A (en) Antimicrobial barrier and treatment of the erosion virus and other human infectious diseases
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
PT1210112E (en) VACCINE AGAINST HBV AND HPV
AU2158000A (en) Treatment of hepatitis c virus infections with interleukin-10
AU2001238501A1 (en) Selective destruction of cells infected with human immunodeficiency virus
NZ310055A (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2292600A (en) Varicella-zoster virus vaccines
IL131212A0 (en) Recombinant virus and live-virus vaccines
AU4553697A (en) Immunogenic peptides of foot-and-mouth disease viruses
AU7465696A (en) Synthetic vaccine for protection against human immunodeficiency virus infection
AU2281601A (en) Treatment of viral infections using levovirinTM
HUP0202770A3 (en) Human papilloma virus vaccine
AU6268199A (en) Live virus vaccines to protect primates from hiv-1 infection and disease
AU7276198A (en) Live virus vaccines to protect primates from hiv-1 infection and disease
AU4957800A (en) Vaccine against isa virus
AU2960000A (en) Detection of human immunodeficiency virus
AU4606000A (en) Vaccine for newcastle disease virus
GB9925432D0 (en) Virus preparation
AU5398296A (en) Vaccine for the immunoprophylaxis of the infection from feli ne immunodeficiency virus in the domestic cat
GB9702990D0 (en) Virus vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase